A large number of studies have found that HDAC inhibitors (HDACIs) can significantly inhibit cancer cell proliferation and metastasis, which may be related to differentiation, immune regulation, chromatin instability, DNA damage repair, oxidative stress, cell cycle arrest, autophagy and angiogenesis [16]. The gene discussed is HDAC9; the disease is cancer.